Team Leader
Matthieu GERARD
matthieu.gerard@cea.fr
This Research Team is part of the I2BC
Define how remodelers regulate genome accessibility and gene expression in three cell types
This three cell type differ in their state of pluripotency, differentiation and proliferation: embryonic stem (ES) cells, neuronal precursor cells and post-mitotic neurons. For this project, we have generated a collection of mouse ES cell lines, each expressing a tagged version of a remodeler. We are using genome-wide approaches including ChIP-seq (chromatin immunoprecipitation sequencing; Figure 1) and loss-of-function coupled to RNA-seq transcriptome analysis, to characterize the genome-wide distribution of remodelers and study their contribution to the regulation of gene expression. Our recent investigations revealed that remodelers have not only key functions in the control of transcriptional programs, but are also essential for the maintenance of the ES cell phenotype. We are currently investigating their functional specificities in neuronal precursor cells and neurons.
Figure 1. ChIP‑seq analysis of histone deacetylase 2 (HDAC2) binding on the mouse prenatal brain genome. (A) Heatmap representation of HDAC2 binding at 14,616 mouse promoters, rank-ordered from highest to lowest HDAC2 occupancy. Red colour means enrichment, white no enrichment. TSS: transcription start site. (B) HDAC2 binding profiles at the promoter of Gria2, Jun and Vamp3, which are examples of genes involved in memory formation or synaptic plasticity.
Analyze the impact of aging on chromatin remodeling and gene expression in the mouse brain.
We are testing the hypothesis that neuronal aging may be associated with progressive alterations of the nucleosomal barrier, resulting in changes in brain transcriptional programs.
Identify and characterize the alterations in remodeler function at different stages of Alzheimer's disease using mouse models.
We are currently studying two remodelers that are the major binding partners of histone deacetylase 2 (HDAC2; Figures 1 and 2) in the brain. It has recently been shown that HDAC2 is overexpressed in Alzheimer's disease patients, resulting in repression of genes required for memory formation and synaptic plasticity, and in cognitive impairment (Gräff et al. 2012; PMID: 22388814). Our aim is to understand how chromatin remodeling and histone deacetylation contribute to dysregulation of genome expression at different stages of the pathology, and to identify novel pathways that could be targeted for early treatment of learning and memory deficits and prevention of cognitive decline.